MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2.
Yali YinShubin HongShuang YuYanrui HuangShu-Wei ChenYujie LiuQuan ZhangYan Bing LiHai-Peng XiaoPublished in: International journal of endocrinology (2017)
These results highlight an important role of miR-195 in the initiation and progression of PTC and implicate the potential application of miR-195 in PTC target therapy.